# Gene Therapy in Treating Patients With Recurrent or Progressive Brain Tumors

> **NCT00004080** · PHASE1 · COMPLETED · sponsor: **National Cancer Institute (NCI)**

## Conditions studied

- Brain and Central Nervous System Tumors

## Interventions

- **BIOLOGICAL:** recombinant adenovirus-p53 SCH-58500
- **PROCEDURE:** conventional surgery

## Key facts

- **NCT ID:** NCT00004080
- **Lead sponsor:** National Cancer Institute (NCI)
- **Sponsor class:** NIH
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1999-12
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2009-02-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00004080

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00004080, "Gene Therapy in Treating Patients With Recurrent or Progressive Brain Tumors". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00004080. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*